Suicidal ideation is common, especially among patients diagnosed with PTSD, mood, personality, and dissociative disorders. It is therefore imperative to critically review our understanding and application of trauma-focused psychotherapies. These therapies, while effective in reducing PTSD and other psychiatric symptoms, pose potential risks, especially in higher-risk groups characterized by chronic suicidality, higher trauma burden, childhood trauma and neglect, and significant comorbidity.
This symposium seeks to bridge the gap between current empirical evidence and the realities of clinical practice in the context of current and novel trauma-focused therapies. Dr. Winkler will review empirical literature, pinpointing research gaps that obscure critical subtleties related to the safety and appropriateness of such therapies. Dr. Burback will present a pioneering mixed methods study on online EMDR therapy targeting experiences related to suicidal thoughts, offering invaluable insights into patient perspectives on perceived risks, benefits, and challenges, while also discussing safety protocols and treatment modifications.
Highlighting the use of Virtual Reality based instrumentation technology in trauma therapy, Dr. Vermetten will present a unique case of complex PTSD using 3MDR. This presentation will examine the potential risks and benefits of this virtual reality-enhanced psychotherapy, particularly its relevance to dissociation, and how treatment can be adapted for complex cases.
Finally, Dr. Richard Lowenstein will draw from his extensive clinical experience, presenting compelling vignettes on the risks and considerations associated with unmodified trauma-focused therapies, especially for patients diagnosed with Dissociative Identity Disorder (DID) and those at a high risk of suicide.
By juxtaposing empirical research with nuanced clinical experience, this symposium invites a conversation on the need for clinicians to consider individual complexities, adapt therapies as needed, and ensure safe practices. The goal is to highlight that, especially with complex populations, details matter and a focus on individualization of therapy can instill hope, promote recovery, and maintain the dignity of our patients.